Literature DB >> 204828

Control of plasma aldosterone in diabetic patients with hyporeninemic hypoaldosteronism.

U Kuhlmann, W Vetter, E Fischer, W Siegenthaler.   

Abstract

In three patients with diabetes and hyporeninemic hypoaldosteronism changes in renin activity, plasma aldosterone and cortisol were examined under various conditions: orthostasis and intravenous furosemide, infusion of synthetic beta1-24 ACTH on two consecutive days and diurnal variations in basal hormone fluctuations. Each patient showed unmeasurably low renin activity unresponsive to orthostasis and intravenous furosemide while plasma aldosterone was below normal range. Under ACTH-infusion only marked increases in aldosterone were observed in one patient whereas cortisol responded normally in all diabetics tested. Analysis of diurnal night day fluctuations (20.00-8.00) in plasma aldosterone and cortisol revealed a close and statistically significant relationship between both hormones in each of the three patients (p less then 0.05-less than 0.001). Variations in plasma aldosterone thus were mediated through changes in endogenous pituitary ACTH. Compared with normal controls however, diurnal aldosterone curves were set at a lower level. Our results demonstrate that a reduced sensitivity of the adrenal gland to ACTH is not responsible for the observed subnormal plasma aldosterone levels in these patients. Therefore, the lack of circulating angiotensin II seems to be the causative reason of hypoaldosteronism. The exact mechanism of undetectable renin activity in these patients remains unknown.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204828     DOI: 10.1007/bf01477829

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  56 in total

1.  ISOLATED ANALDOSTERONISM. I. CLINICAL ENTITY, WITH MANIFESTATIONS OF PERSISTENT HYPERKALEMIA, PERIODIC PARALYSIS, SALT-LOSING TENDENCY, AND ACIDOSIS.

Authors:  J B POSNER; D R JACOBS
Journal:  Metabolism       Date:  1964-06       Impact factor: 8.694

2.  SELECTIVE HYPOALDOSTERONISM AFTER PROLONGED HEPARIN ADMINISTRATION. A CASE REPORT, WITH POSTMORTEM FINDINGS.

Authors:  I D WILSON; F C GOETZ
Journal:  Am J Med       Date:  1964-04       Impact factor: 4.965

3.  Hypoaldosteronism; a clinical study of a patient with an isolated adrenal mineralocorticoid deficiency, resulting in hyperkalemia and Stokes-Adams attacks.

Authors:  J B HUDSON; A V CHOBANIAN; A S RELMAN
Journal:  N Engl J Med       Date:  1957-09-19       Impact factor: 91.245

4.  The effect of dexamethasone on the control of plasma aldosterone concentration in normal recumbent man.

Authors:  M H Weinberger; D C Kem; C Gomez-Sanchez; N J Kramer; B T Martin; C A Nugent
Journal:  J Lab Clin Med       Date:  1975-06

5.  Problems connected with plasma renin activity measurements by angiotensin I radioimmunoassay.

Authors:  R Beckerhoff; J Nussberger; W Vetter; W Siegenthaler
Journal:  Horm Metab Res       Date:  1975-07       Impact factor: 2.936

6.  Intradiem changes of plasma aldosterone, cortisol, corticosterone and growth hormone in sodium restriction.

Authors:  A H Vagnucci; R H McDonald; A L Drash; A K Wong
Journal:  J Clin Endocrinol Metab       Date:  1974-05       Impact factor: 5.958

7.  Radioimmunoassay for aldosterone without chromatography.

Authors:  W Vetter; H Vetter; W Siegenthaler
Journal:  Acta Endocrinol (Copenh)       Date:  1973-11

8.  Isolated hypoaldosteronism.

Authors: 
Journal:  Calif Med       Date:  1973-06

9.  [Diurnal profiles of plasma aldosterone, cortisol, renin, angiotensinogen and angiotensinases in normal subjects (author's transl)].

Authors:  D Lommer; A Distler; H P Nast; K Sinterhauf; U Walter; H P Wolff; K Sieler
Journal:  Klin Wochenschr       Date:  1976-02-01

10.  Plasma renin activity and hypertension in diabetes mellitus.

Authors:  A R Christlieb; A Kaldany; J A D'Elia
Journal:  Diabetes       Date:  1976-10       Impact factor: 9.461

View more
  1 in total

Review 1.  Therapeutic Renin Inhibition in Diabetic Nephropathy-A Review of the Physiological Evidence.

Authors:  Bianca Domingues Massolini; Stephanie San Gregorio Contieri; Giulia Severini Lazarini; Paula Antoun Bellacosa; Mirela Dobre; Georg Petroianu; Andrei Brateanu; Luciana Aparecida Campos; Ovidiu Constantin Baltatu
Journal:  Front Physiol       Date:  2020-03-12       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.